Physician profile
Lisa E Trivedi
NPI 1497285357
$8,075.19
in general payments reported to CMS, 2019-2025
35 companies · $2,407 in 2025
The $2,407 reported for 2025 was more than what 80% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2020: $19.99 · 2021: $406 · 2022: $963 · 2023: $1,915 · 2024: $2,246 · 2025: $2,407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,302 · Education: $267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,301.72 |
| Education | $267.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,103.77 | 2021-2025 | |
| Abbvie INC. | $786.22 | 2019-2025 | Skyrizi, Rinvoq |
| Incyte Corporation | $653.18 | 2021-2025 | Opzelura |
| Regeneron Healthcare Solutions, INC. | $625.80 | 2021-2025 | Dupixent, Libtayo |
| Janssen Biotech, INC. | $585.01 | 2023-2025 | Tremfya |
| Lilly USA, LLC | $520.28 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| Ucb, INC. | $513.40 | 2021-2025 | Bimzelx, Cimzia |
| Pfizer INC. | $480.77 | 2021-2025 | |
| Amgen INC. | $368.96 | 2021-2025 | Otezla, Otezla |
| E.R. Squibb & Sons, L.L.C. | $316.34 | 2023-2025 | Sotyktu |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $270.98 | 2021-2025 | Cabtreo, Jublia, Siliq |
| Sun Pharmaceutical Industries INC. | $269.66 | 2021-2024 | Absorica Ld, Winlevi |
| Galderma Laboratories, L.P. | $244.94 | 2022-2025 | Nemluvio, Aklief, Oracea |
| Leo Pharma INC. | $235.06 | 2020-2025 | Adbry, Anzupgo |
| Dermavant Sciences, INC. | $184.35 | 2023-2024 | Vtama |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $166.38 | 2023-2025 | |
| Genzyme Corporation | $164.37 | 2022-2025 | |
| Organogenesis INC. | $100.37 | 2023-2025 | Puraply, Novachor |
| Almirall LLC | $68.05 | 2022 | |
| Paratek Pharmaceuticals, INC. | $49.67 | 2022 | |
| Medtronic, INC. | $47.38 | 2022 | |
| Convatec INC. | $36.67 | 2024 | |
| Botanix Sb INC | $31.92 | 2025 | Sofdra |
| Smith+Nephew, INC. | $30.95 | 2025 | Collagenase Santyl |
| Arcutis Biotherapeutics, INC. | $30.34 | 2024 | Zoryve |
| Chiesi USA, INC. | $29.22 | 2025 | Filsuvez |
| Mallinckrodt Hospital Products INC. | $21.56 | 2024 | Acthar |
| Integra Lifesciences Corporation | $21.55 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Nabriva Therapeutics, Plc | $19.06 | 2022 | |
| Biofrontera INC. | $18.80 | 2023 | Xepi, Bf-Rhodoled, Ameluz |
| Lnhc, INC | $18.28 | 2025 | Zelsuvmi |
| Kerecis Limited | $17.44 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Strata Skin Sciences, INC. | $16.87 | 2025 | Xtrac |
| Medline Industries LP | $14.22 | 2021 | |
| Organon LLC | $13.37 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Trivedi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.